Despite poor growth, the company trades at a market-comparable P/E ratio, indicating investor hopes for a business turnaround. However, continued earnings trends may lead to share price decline, risking investors paying an unnecessary premium. Three warning signs for Zhejiang Garden Biopharmaceutical Co.,Ltd. should also be considered.
Zhejiang Garden Biopharmaceutical Stock Forum
No comment yet